GLP-1 RAs and Metformin May Offer Different Clinical Benefits in antipsychotic-induced metabolic disturbances: Study

A new study published in the journal of BMC Medicine showed that GLP-1 receptor agonists and metformin could potentially provide distinct clinical advantages in managing metabolic complications...
Read the full report on Business Medical Dialogues
Story file
- Section
- India
- First reported by
- Business Medical Dialogues
- Reporter
- jacinthlyn sylvia
- Published
- Thursday, 15 October 2026, 9:15 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.




